BMS, Pfizer secure victory over generic makers
07-08-2020
Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal
03-08-2020
photobyphm / Shutterstock.com
Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Pfizer, BioNTech, COVID-19, vaccine, US, Donald Trump, Operation Warp Speed, FDA, vaccine programme, Evotec
